The Treatment and Prognosis of Subclasses in Early-Stage Hepatocellular Carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240906002

Enrollment

272

Registered

2024-09-06

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early-stage hepatocellular carcinoma hepatocellular carcinoma HCC

Interventions

Early-stage HCC patients with single tumor larger than 5 cm ,Early-stage HCC patients with single tumor smaller than 5 cm

Treatment,Treatment

Large tumor,Non-large tumor

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: early-stage HCC treated within Thammasat University Hospital

Exclusion criteria

Exclusion criteria: incomplete clinical or radiologic information in electronic medical record

Design outcomes

Primary

Measure	Time frame
survival rate 5 years percentage	—

Secondary

Measure	Time frame
Median survival time 5 years months	—

Countries

Thailand

Contacts

Public ContactAssanee Tongyoo

Faculty of Medicine, Thammasat University

assaneetongyoo@gmail.com029269523

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026